Martingale Asset Management’s Pediatrix Medical MD Stock Holding History

Martingale Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.41M	Sell	159,580 -10,018	-6%	-$209K	0.09%	228
2025 Q4	$3.63M	Sell	169,598 -8,567	-5%	-$176K	0.09%	199
2025 Q3	$2.98M	Buy	178,165 +605	+0.3%	+$9.07K	0.08%	228
2025 Q2	$2.55M	Buy	177,560 +109,000	+159%	+$1.49M	0.06%	258
2025 Q1	$993K	Sell	68,560 -12,408	-15%	-$176K	0.03%	460
2024 Q4	$1.06M	Sell	80,968 -6,098	-7%	-$84.2K	0.03%	464
2024 Q3	$1.01M	Buy	87,066 +55,966	+180%	+$528K	0.02%	454
2024 Q2	$235K	Sell	31,100 -31,401	-50%	-$260K	0.01%	732
2024 Q1	$627K	Hold	62,501	–	–	0.01%	571
2023 Q4	$581K	Buy	62,501 +1,500	+2%	+$15.5K	0.01%	576
2023 Q3	$775K	Buy	61,001 +48,700	+396%	+$668K	0.02%	514
2023 Q2	$175K	Sell	12,301 -6,500	-35%	-$91.3K	﹤0.01%	775
2023 Q1	$280K	Buy	+18,801	New	+$285K	0.01%	720
2020 Q4	–	Sell	-20,432	Closed	-$333K	–	985
2020 Q3	$333K	Buy	+20,432	New	+$380K	﹤0.01%	892

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Martingale Asset Management's MD Position: Q1 2026 in Review

Martingale Asset Management reduced its Pediatrix Medical (MD) stake by 5.9% in Q1 2026, selling an estimated $209K and leaving 159,580 shares worth $3.41M. The position accounts for 0.09% of the portfolio, ranked #228.

Martingale Asset Management first reported a position in MD in Q3 2020 and has held it in 14 quarters since. The position peaked at $3.63M in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Martingale Asset Management held 159,580 shares of Pediatrix Medical worth $3.41M as of Q1 2026.
Martingale Asset Management sold 10,018 Pediatrix Medical shares in Q1 2026, an estimated $209K.
Pediatrix Medical made up 0.09% of Martingale Asset Management's portfolio in Q1 2026, its #228 holding.
Martingale Asset Management first reported a position in Pediatrix Medical in Q3 2020 and has held it in 14 quarters since.
Martingale Asset Management's Pediatrix Medical position peaked at $3.63M in Q4 2025.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.